Focal low-dose rate brachytherapy for the treatment of prostate cancer.

Whole-gland low-dose rate (LDR) brachytherapy has been a well-established modality of treating low-risk prostate cancer. Treatment in a focal manner has the advantages of reduced toxicity to surrounding organs. Focal treatment using LDR brachytherapy has been relatively unexplored, but it may offer advantages over other modalities that have established experiences with a focal approach. This is particularly true as prostate cancer is being detected at an earlier and more localized stage with the advent of better detection methods and newer imaging modalities.

Citation

William Y Tong, Gilad Cohen, Yoshiya Yamada. Focal low-dose rate brachytherapy for the treatment of prostate cancer. Cancer management and research. 2013;5:315-25

PMID: 24049459

search → result